AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 43 filers reported holding AQUESTIVE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | -100.0% | 1 | -99.9% | 0.00% | – |
| Q2 2022 | $727,000 | -99.2% | 1,136 | -96.7% | 0.00% | – |
| Q1 2022 | $90,854,000 | +46.4% | 34,810 | +118.2% | 0.00% | – |
| Q4 2021 | $62,046,000 | +12065.9% | 15,950 | +13532.5% | 0.00% | – |
| Q3 2021 | $510,000 | -41.8% | 117 | -47.1% | 0.00% | – |
| Q2 2021 | $877,000 | -93.2% | 221 | -91.1% | 0.00% | – |
| Q1 2021 | $12,974,000 | -27.9% | 2,495 | -25.8% | 0.00% | – |
| Q4 2020 | $17,992,000 | -12.8% | 3,363 | -20.9% | 0.00% | – |
| Q3 2020 | $20,634,000 | +470.6% | 4,250 | +471.2% | 0.00% | – |
| Q2 2020 | $3,616,000 | +3552.5% | 744 | +1553.3% | 0.00% | – |
| Q1 2020 | $99,000 | -62.2% | 45 | 0.0% | 0.00% | – |
| Q4 2019 | $262,000 | -94.1% | 45 | -96.8% | 0.00% | – |
| Q3 2019 | $4,449,000 | -24.3% | 1,399 | 0.0% | 0.00% | – |
| Q2 2019 | $5,876,000 | -65.8% | 1,399 | -43.8% | 0.00% | – |
| Q1 2019 | $17,199,000 | – | 2,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 11,503,294 | $66,949,000 | 80.13% |
| Opaleye Management Inc. | 738,500 | $4,298,000 | 0.84% |
| Wildcat Capital Management, LLC | 455,358 | $2,650,000 | 0.76% |
| One68 Global Capital, LLC | 34,543 | $201,000 | 0.43% |
| Eversept Partners, LP | 350,000 | $2,037,000 | 0.36% |
| Worth Venture Partners, LLC | 94,500 | $550,000 | 0.27% |
| Leap Investments LP | 71,809 | $418,000 | 0.20% |
| Bracebridge Capital, LLC | 428,571 | $2,000,000 | 0.16% |
| Granite Point Capital Management, L.P. | 160,099 | $932,000 | 0.15% |
| True North Advisors, LLC | 32,295 | $187,000 | 0.05% |